References
- Morrison, J.H., Hof, P.R. Life and death of neurons in the aging brain. Science 278: 412-419, 1997. https://doi.org/10.1126/science.278.5337.412
- Fraser, P.E., Lévesque, L., McLachian, D.R. Biochemistry of Alzheimer's disease amyloid plaques. Clin. Biochem. 26:339-349, 1993. https://doi.org/10.1016/0009-9120(93)90110-R
- Checler, F. Processing of the b-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65: 1431-1444, 1995.
- Davies, P., Maloney, A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 308: 1403, 1976.
- Stefani, M., Dobson, C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81: 678-699, 2003. https://doi.org/10.1007/s00109-003-0464-5
- Chiti, F., Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75: 333-366, 2006. https://doi.org/10.1146/annurev.biochem.75.101304.123901
- Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhang, C., Finch, C.E., Krafft, G.A., Klein, W.L. Diffusible, nonfibrillar ligands derived from Ab1-42 are potent contral nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95: 6448-6453, 1998. https://doi.org/10.1073/pnas.95.11.6448
- Klein, W.L., Krafft, G.A., Finch, C.E. Targeting small Ab oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24: 219-224, 2001. https://doi.org/10.1016/S0166-2236(00)01749-5
- Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., Selkoe, D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long term potentiation in vivo. Nature 416: 535-539, 2002. https://doi.org/10.1038/416535a
- 國家中醫藥管理局. 中華本草(第8卷). 上海: 上海科學技術出版社, pp 472-478, 1999.
- 전국한의과대학 공동교재편찬위원회, 본초학, 영림사, pp 563-564, 2011
- Findeis, M.A. Approaches to discovery and characterization of inhibitors of amyloid b-peptide polymerization. Biochim. Biophys. Acta 1502: 76-84, 2000. https://doi.org/10.1016/S0925-4439(00)00034-X
- Talaga, P. beta-Amyloid aggregation inhibitors for the treatment of Alzheimer's disease: dream or reality? Mini Rev. Med. Chem. 1: 175-186, 2001. https://doi.org/10.2174/1389557013407098
- Selkoe, D.J. Alzheimer's disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140: 627-638, 2004. https://doi.org/10.7326/0003-4819-140-8-200404200-00010
- Tjernberg, L.O., Naslund, J., Lindqvist, F., Johanson, J., Karlstrom, A.R., Thyberg, J., Terenius, L., Nordstedt, C. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271: 8545-8548, 1996. https://doi.org/10.1074/jbc.271.15.8545
- Permanne, B., Adessi, C., Fraga, S., Frossard, M.J., Saborio, G.P., Soto, C. Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease? J. Neural Transm. Suppl. 62: 293-301, 2002. https://doi.org/10.1007/978-3-7091-6139-5_27
- Adessi, C., Frossard, M.-J., Boissard, C., Fraga, S., Bieler, S., Ruckle, T., Vilbois, F., Robinson, S. M., Mutter, M., Banks, W. A., Soto, C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J. Biol. Chem. 278: 13905-13911, 2003. https://doi.org/10.1074/jbc.M211976200
- Feng, B.Y., Toyama, B.H., Wille, H., Colby, D.W., Collins, S. R., May, B.C.H., Prusiner, S.B., Weissman, J., Shoichet, B.K. Small-molecule aggregates inhibit amyloid polymerization. Nat. Chem. Biol. 4: 197-199, 2008. https://doi.org/10.1038/nchembio.65
- Necula, M., Kayed, R., Milton, S., Glabe, C.G. Small molecule inhibitors of aggregation indicate that amyloid b oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282: 10311-10324, 2007. https://doi.org/10.1074/jbc.M608207200
- Geng, Y., Li, C., Liu, J., Xing, G., Zhou, L., Dong, M., Li, X., Niu, Y. Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biological & Pharmaceutical Bulletin. 33: 836-843, 2010. https://doi.org/10.1248/bpb.33.836
- Matthew, B.i., Shohei, K. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochimica et Biophysica Acta 1804: 1405-1412, 2010 https://doi.org/10.1016/j.bbapap.2010.04.001
-
Mahiuddin, A., Judianne, D., Darryl, A., Takeshi, S., Shivani, A., Saburo, A., James, I.E., William, E.V. & Steven, O.S. Structural conversion of neurotoxic amyloid-
$\beta$ 1-42 oligomers to fibrils. Nature Structural. and Molecular bio. 17: 561-567, 2010. https://doi.org/10.1038/nsmb.1799 - Barrow, C.J., Yasuda, A., Kenny, P.T., Zagorski, M.G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225: 1075-1093, 1992. https://doi.org/10.1016/0022-2836(92)90106-T
- Datki, Z., Juhasz, A., Galfi, M., Soós, K., Papp, R., Zadori, D., Penke, B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull. 62: 223-229, 2003. https://doi.org/10.1016/j.brainresbull.2003.09.011